$AIMD
Ainos, Inc.

2021 Q3 Form 10-Q Financial Statement

#000165495421009289 Filed on August 20, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q2
Revenue $363.1K $203.0K $484.00
YoY Change 188989.58% 41840.5% -20.13%
Cost Of Revenue $103.6K $69.51K $292.00
YoY Change 84158.54% 23704.11% -48.13%
Gross Profit $259.4K $133.5K $192.00
YoY Change 375862.32% 69422.92% 346.51%
Gross Profit Margin 71.45% 65.76% 39.67%
Selling, General & Admin $796.0K $860.0K $300.5K
YoY Change 147.84% 186.23% -25.8%
% of Gross Profit 306.83% 644.29% 156495.83%
Research & Development $646.8K $0.00 $389.00
YoY Change -100.0% -99.22%
% of Gross Profit 249.33% 0.0% 202.6%
Depreciation & Amortization $514.9K
YoY Change
% of Gross Profit 385.7%
Operating Expenses $1.443M -$860.0K $300.9K
YoY Change 349.24% -385.86% -33.89%
Operating Profit -$1.183M -$726.5K -$300.7K
YoY Change 268.55% 141.64% -33.92%
Interest Expense $23.52K $3.417K $1.297K
YoY Change -1168.61% 163.45% -14.78%
% of Operating Profit
Other Income/Expense, Net $1.443M -$860.0K -$300.9K
YoY Change 349.24% 185.86%
Pretax Income -$1.160M -$749.8K -$302.0K
YoY Change 258.85% 148.3% -32.9%
Income Tax
% Of Pretax Income
Net Earnings -$1.160M -$749.8K -$302.0K
YoY Change 258.85% 148.3% -33.42%
Net Earnings / Revenue -319.54% -369.36% -62389.67%
Basic Earnings Per Share
Diluted Earnings Per Share -$122.2K -$90.22K -$0.11
COMMON SHARES
Basic Shares Outstanding 142.4M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $706.9K $606.6K $170.0K
YoY Change 783.66% 256.85% -76.39%
Cash & Equivalents $706.9K $606.6K $172.8K
Short-Term Investments
Other Short-Term Assets $133.1K $123.1K $10.00K
YoY Change 90.1% 1130.9% -83.33%
Inventory $173.7K $0.00 $3.675K
Prepaid Expenses
Receivables $44.64K $139.7K $751.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $884.8K $869.5K $191.8K
YoY Change 460.26% 353.3% -75.96%
LONG-TERM ASSETS
Property, Plant & Equipment $39.96K $22.92K $3.904K
YoY Change 1017.34% 487.17% -38.85%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.795K
YoY Change
Total Long-Term Assets $19.11M $19.75M $145.2K
YoY Change 13230.18% 13507.58% -1.26%
TOTAL ASSETS
Total Short-Term Assets $884.8K $869.5K $191.8K
Total Long-Term Assets $19.11M $19.75M $145.2K
Total Assets $19.99M $20.62M $337.0K
YoY Change 6536.23% 6019.91% -64.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $578.6K $310.5K $290.0K
YoY Change 60.71% 7.06% 70.59%
Accrued Expenses $31.98K $20.57K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $2.185M $1.711M $580.0K
YoY Change 246.86% 195.07% 20.83%
Long-Term Debt Due $2.000M $1.530M
YoY Change
Total Short-Term Liabilities $2.822M $2.376M $880.9K
YoY Change 161.83% 169.75% 24.89%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $35.29K $40.58K
YoY Change
Total Long-Term Liabilities $35.29K $40.58K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.822M $2.376M $880.9K
Total Long-Term Liabilities $35.29K $40.58K $0.00
Total Liabilities $2.857M $2.417M $880.9K
YoY Change 165.1% 174.36% 24.89%
SHAREHOLDERS EQUITY
Retained Earnings -$8.664M -$7.504M -$5.448M
YoY Change 50.11% 37.73% 35.09%
Common Stock $1.424M $1.423M $409.2K
YoY Change 248.13% 247.71% 3.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $17.14M $18.21M -$744.1K
YoY Change
Total Liabilities & Shareholders Equity $19.99M $20.62M $337.0K
YoY Change 6536.23% 6019.91% -64.34%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$1.160M -$749.8K -$302.0K
YoY Change 258.85% 148.3% -33.42%
Depreciation, Depletion And Amortization $514.9K
YoY Change
Cash From Operating Activities -$526.2K -$42.93K -$120.0K
YoY Change 209.54% -64.23% -62.5%
INVESTING ACTIVITIES
Capital Expenditures $23.31K -$23.31K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$43.38K $40.00
YoY Change
Cash From Investing Activities -$20.06K -$23.28K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 639.5K 650.6K 10.00K
YoY Change 699.41% 6406.0%
NET CHANGE
Cash From Operating Activities -526.2K -42.93K -120.0K
Cash From Investing Activities -20.06K -23.28K 0.000
Cash From Financing Activities 639.5K 650.6K 10.00K
Net Change In Cash 93.25K 584.4K -110.0K
YoY Change -203.61% -631.26% -65.63%
FREE CASH FLOW
Cash From Operating Activities -$526.2K -$42.93K -$120.0K
Capital Expenditures $23.31K -$23.31K $0.00
Free Cash Flow -$549.5K -$19.62K -$120.0K
YoY Change 223.25% -83.65% -62.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Convertible Debt
ConvertibleDebt
185000 USD
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
142442215 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
606638 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22245 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
139747 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
0 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
3024 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
123085 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
51144 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
869470 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
76413 USD
CY2021Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
19668879 USD
CY2020Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
180628 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22923 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3249 USD
CY2021Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
61100 USD
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0 USD
CY2021Q2 us-gaap Assets
Assets
20622372 USD
CY2020Q4 us-gaap Assets
Assets
260290 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
310481 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
145567 USD
CY2021Q2 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
333763 USD
CY2020Q4 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
0 USD
CY2021Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1526420 USD
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
805001 USD
CY2020Q4 us-gaap Convertible Debt
ConvertibleDebt
148000 USD
CY2021Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
20568 USD
CY2020Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
0 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2376232 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1098568 USD
CY2021Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
40583 USD
CY2020Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
0 USD
CY2021Q2 us-gaap Liabilities
Liabilities
2416815 USD
CY2020Q4 us-gaap Liabilities
Liabilities
1098568 USD
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
1422718 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
420662 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24286874 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4961315 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7504035 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6220255 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
18205557 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-838278 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20622372 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
260290 USD
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
142271815 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42066172 shares
CY2021Q2 us-gaap Revenues
Revenues
202992 USD
CY2020Q2 us-gaap Revenues
Revenues
484 USD
us-gaap Revenues
Revenues
205113 USD
us-gaap Revenues
Revenues
15684 USD
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
69508 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
292 USD
us-gaap Cost Of Revenue
CostOfRevenue
70757 USD
us-gaap Cost Of Revenue
CostOfRevenue
11098 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
133484 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
192 USD
us-gaap Gross Profit
GrossProfit
134356 USD
us-gaap Gross Profit
GrossProfit
4586 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
389 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
389 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
860030 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
300472 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1383011 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
680740 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-860030 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-300861 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1383011 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-681129 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-726546 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-300669 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1248655 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-676543 USD
CY2021Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-2247 USD
CY2020Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-2247 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
20981 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
1297 USD
us-gaap Interest Expense
InterestExpense
32879 USD
us-gaap Interest Expense
InterestExpense
2302 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-749774 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-301966 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1283781 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-678845 USD
CY2021Q2 amar Less Income Tax
LessIncomeTax
0 USD
CY2020Q2 amar Less Income Tax
LessIncomeTax
0 USD
amar Less Income Tax
LessIncomeTax
0 USD
amar Less Income Tax
LessIncomeTax
0 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-749774 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-301966 USD
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
124644759 shares
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40516351 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
83583583 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40516351 shares
us-gaap Net Income Loss
NetIncomeLoss
-1283781 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
18205557 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-156682 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
100000 USD
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
10218 USD
amar Option Expense
OptionExpense
181376 USD
us-gaap Net Income Loss
NetIncomeLoss
-678845 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-543933 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-44726 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-244967 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1278179 USD
CY2021Q2 amar Issuance Of Stock For Compensation Amount
IssuanceOfStockForCompensationAmount
139405 USD
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20000000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
3417 USD
CY2021Q2 amar Option Expense
OptionExpense
90688 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-749774 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
18205557 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-433377 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
100000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
722 USD
CY2020Q2 amar Option Expense
OptionExpense
90688 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-301966 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-543933 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-838278 USD
amar Issuance Of Stock For Compensation Amount
IssuanceOfStockForCompensationAmount
139405 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
20000000 USD
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
6835 USD
amar Option Expense
OptionExpense
181376 USD
amar Investment In Patents
InvestmentInPatents
0 USD
amar Investment In Patents
InvestmentInPatents
-1270 USD
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
23276 USD
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23276 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1270 USD
amar Advances From Shareholder
AdvancesFromShareholder
0 USD
amar Advances From Shareholder
AdvancesFromShareholder
10000 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
652395 USD
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
652395 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
584393 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-236237 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22245 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
409039 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
606638 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
172802 USD
us-gaap Interest Paid Net
InterestPaidNet
132 USD
us-gaap Interest Paid Net
InterestPaidNet
25 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
amar Stock Issued For Acquisition Of Patents
StockIssuedForAcquisitionOfPatents
20000000 USD
amar Stock Issued For Acquisition Of Patents
StockIssuedForAcquisitionOfPatents
0 USD
amar Stock Issued For Compensation Warrant And Option Expense
StockIssuedForCompensationWarrantAndOptionExpense
224711 USD
amar Stock Issued For Compensation Warrant And Option Expense
StockIssuedForCompensationWarrantAndOptionExpense
194690 USD
CY2021Q2 amar Notes Payable Convertible Related Parties Current
NotesPayableConvertibleRelatedPartiesCurrent
9025 USD
amar Stock Issued For Advances From Investors
StockIssuedForAdvancesFromInvestors
0 USD
amar Stock Issued For Advances From Investors
StockIssuedForAdvancesFromInvestors
100000 USD
amar Rou Leased Assets
RouLeasedAssets
62846 USD
amar Rou Leased Assets
RouLeasedAssets
0 USD
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
62846 USD
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
0 USD
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font-size:10pt;font-family:times new roman;margin:0px"> <strong>Basis of presentation.</strong> The accompanying consolidated financial statements, which should be read in conjunction with the audited financial statements and footnotes included in the Company's Form 10-K for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on March 30, 2021 attached hereto as Exhibit 13 and which is incorporated by this reference, have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2021, are not necessarily indicative of the results that may be expected for the full year ending December 31, 2021.</p>
amar Shares Issued For Common Stock
SharesIssuedForCommonStock
154043192 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
142271815 shares
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
6661760 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4657000 shares
CY2020Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
953001 USD
CY2021Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1711421 USD
CY2021Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1711421 USD
CY2020Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
953001 USD
CY2021Q2 amar Short Term Interest Rate
ShortTermInterestRate
0.1000 pure
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
37000 USD
CY2021Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0185 pure
us-gaap Officers Compensation
OfficersCompensation
37000 USD
CY2021Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.25

Files In Submission

Name View Source Status
0001654954-21-009289-index-headers.html Edgar Link pending
0001654954-21-009289-index.html Edgar Link pending
0001654954-21-009289.txt Edgar Link pending
0001654954-21-009289-xbrl.zip Edgar Link pending
amar-20210630.xsd Edgar Link pending
amar-20210630_cal.xml Edgar Link unprocessable
amar-20210630_def.xml Edgar Link unprocessable
amar-20210630_lab.xml Edgar Link unprocessable
amar-20210630_pre.xml Edgar Link unprocessable
amar_10q.htm Edgar Link pending
amar_10q_htm.xml Edgar Link completed
amar_ex311.htm Edgar Link pending
amar_ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending